The main purpose of this legislation, known as the Maternal and Infant Syphilis Prevention Act, is to improve the screening and treatment of congenital syphilis, particularly through Medicaid and the Children's Health Insurance Program (CHIP). The goal is to reduce the rising rates of congenital syphilis, which can lead to serious health issues for infants and mothers. Key provisions of the Act require the Secretary of Health and Human Services to provide guidance to state agencies on best practices for screening and treating syphilis in pregnant women and newborns.